ロード中...
Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
In 1999, the UK introduced meningococcal serogroup C conjugate (MCC) vaccination at 2, 3, 4 months of age with a single dose for children 1–18 y In 2006, the schedule was refined to a 2 dose priming schedule with a booster in the second year of life. In 2013, the number of priming doses was reduced...
保存先:
| 出版年: | Hum Vaccin Immunother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514293/ https://ncbi.nlm.nih.gov/pubmed/25912095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1019189 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|